Hyundai Motor Group Commits to U.S. Growth with USD 21 Billion Investment

Hyundai Motor Group Commits to U.S. Growth with USD 21 Billion Investment

The Group to invest a total of USD 21 billion in the U.S. from 2025 to 2028 USD 9 billion to expand U.S. automobile production to 1.2 million units annually USD 6 billion to enhance parts, logistics and steel business, increasing the localization of...

SKIMS ACQUIRES SKKN BY KIM FROM KIM KARDASHIAN AND COTY, BRINGING KARDASHIAN'S BEAUTY NIL RIGHTS & VENTURES UNDER THE SKIMS BRAND

SKIMS ACQUIRES SKKN BY KIM FROM KIM KARDASHIAN AND COTY, BRINGING KARDASHIAN'S BEAUTY NIL RIGHTS & VENTURES UNDER THE SKIMS BRAND

LOS ANGELES, March 25, 2025 /PRNewswire/ -- SKIMS, the lifestyle company co-founded by Kim Kardashian and Jens Grede, has acquired SKKN by Kim from Kim Kardashian and COTY, bringing her beauty NIL rights and ventures under the SKIMS brand. This bold...

Get a sneak peek at the highlights: Tourism Plus Shanghai 2025 promotes innovation

Get a sneak peek at the highlights: Tourism Plus Shanghai 2025 promotes innovation

SHANGHAI, March 19, 2025 /PRNewswire/ -- Recording a new high scale: From March 30th to April 3rd, 2025, Tourism Plus Shanghai 2025 will create a new record with five collective exhibitions and four pavilions in Pudong and Puxi, covering a total...

Korea's Leading EdTech 'ZEP QUIZ' Officially Launches in Thailand

Korea's Leading EdTech 'ZEP QUIZ' Officially Launches in Thailand

- ZEP expands to Thailand just a month after entering Indonesia, recording 1 million plays during its beta service period. - 'ZEP QUIZ' holds the number 1 spot for metaverse-based Edtech platform in the Korean education market SEOUL, South Korea,...

Australian Startups Gain Strategic U.S. Market Entry Through New Initiative from Mercurius Media Capital

Australian Startups Gain Strategic U.S. Market Entry Through New Initiative from Mercurius Media Capital

Strategic Support and Resources to Accelerate U.S. Expansion SYDNEY, March 18, 2025 /PRNewswire/ -- Mercurius Media Capital (MMC) has launched Mercurius Bridge in Australia, empowering local startups and growth-stage companies with established...

Automotive Sector Poised for Major Shifts Amid EV Expansion and Fiercer Competition

Automotive Sector Poised for Major Shifts Amid EV Expansion and Fiercer Competition

Strategic partnerships, expanded EV portfolios, and new production hubs set to reshape the global automotive landscape LONDON, March 18, 2025 /PRNewswire/ -- The global automotive industry is undergoing a significant transformation, with 2025 poised...

InPsytech Joins Intel Foundry Accelerator IP Alliance to Boost HPC, AI, And Automotive Applications

InPsytech Joins Intel Foundry Accelerator IP Alliance to Boost HPC, AI, And Automotive Applications

HSINCHU, March 14, 2025 /PRNewswire/ -- InPsytech, Inc., a leading provider of high-performance semiconductor intellectual property (IP) solutions under Egis Group, is pleased to announce its participation in the Intel Foundry Accelerator IP...

MSIG USA Partners with MSIG Singapore and MSIG Hong Kong to Strengthen Political Risk and Trade Credit Business in Asia

MSIG USA Partners with MSIG Singapore and MSIG Hong Kong to Strengthen Political Risk and Trade Credit Business in Asia

NEW YORK, March 13, 2025 /PRNewswire/ -- MSIG USA has launched a strategic collaboration with MSIG Singapore and MSIG Hong Kong to expand the Group's political risk and trade credit business in Asia. This initiative reinforces MSIG's commitment to...

THE KOREA INDUSTRY DAILY: 12 Leading Korean Carbon Companies Participated in JEC WORLD 2025

THE KOREA INDUSTRY DAILY: 12 Leading Korean Carbon Companies Participated in JEC WORLD 2025

- Achieved Approximately $700,000 in Export Agreements and Strengthened Global Collaboration Networks – PARIS, March 13, 2025 /PRNewswire/ -- The Korea Carbon and Nano Industry Association and the World Federation of Overseas Korean Traders...

STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), now available in the United States

STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), now available in the United States

STEQEYMA ® , one of the first-wave biosimilars to STELARA®, is now available in the U.S. Approved for the same indications as the reference product, STEQEYMA will be priced with a wholesale acquisition cost (WAC) list price at an 85% discount to the...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 14
  • menu
    menu